LNTH (Lantheus Holdings) Other Financing: $-7 Mil (TTM As of Mar. 2026)


LNTH Lantheus Holdings Inc LNTH
82 GF Score
Price $108.93
GF Value $90.85
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Lantheus Holdings Other Financing?

Lantheus Holdings LNTH -1.78% 82 Other Financing is $-7 Mil as of Mar. 2026. GuruFocus rates LNTH with a GF Score™ of 82/100 and a GF Value™ of $90.85 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Lantheus Holdings's Other Financing for the three months ended in Mar. 2026 was $-11 Mil.

Lantheus Holdings's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $-7 Mil.

Lantheus Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Lantheus Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings Other Financing Chart

Lantheus Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.25 2.95 -14.28 -21.67 -19.18

Lantheus Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.80 3.63 1.13 -0.42 -11.41
LNTH
82GF Score
Lantheus Holdings Inc LNTH
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantheus Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-7 Mil mean?
Lantheus Holdings (LNTH) has a Other Financing of $-7 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lantheus Holdings and its competitors.
Is Lantheus Holdings' Other Financing too high?
Lantheus Holdings' current Other Financing is $-7 Mil. Overall, Lantheus Holdings has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lantheus Holdings' Other Financing compare to LQDA and HIMS?
Lantheus Holdings' Other Financing of $-7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Lantheus Holdings and its competitors. Lantheus Holdings's current Other Financing is $-7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantheus Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lantheus Holdings (LNTH) is currently considered Modestly Overvalued. The stock's GF Value™ is $90.85, compared to a current price of $108.93 — trading 19.9% above its estimated fair value. The current Other Financing is $-7 Mil. Lantheus Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Lantheus Holdings (LNTH), the current Other Financing is $-7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lantheus Holdings (LNTH) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of $108.93 is trading 19.9% above its estimated GF Value™ of $90.85. GuruFocus considers Lantheus Holdings to be Modestly Overvalued.

Key valuation signals for LNTH:

  • Other Financing: $-7 Mil
  • GF Value™: $90.85 vs. price of $108.93 (19.9% above fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the LNTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lantheus Holdings Business Description

Other Exchanges 1LNTH:Italy0L8:Germany
Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
82GF Score

Get the complete analysis for LNTH

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$108.93
Price
$90.85
GF Value